Clinical Trial Update: A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 [Phase 2]

View source ↗

Summary

Phase 2 trial update characterizing pharmacodynamics and safety of repeat-dose SP-102 in lumbosacral radicular pain; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbosacral Radicular Pain

Drugs mentioned

• SP-102

Snippet

Sponsor: Semnur Pharmaceuticals, Inc. | Conditions: Lumbosacral Radicular Pain | Phase 2 | Status: COMPLETED | Results posted: 2022-01-13